Delivery Order SPE2DB22D2007-SPE2DB24FH9UR
Award Date 2/21/24
Potential Completion Date 3/13/24
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the specialty pharmaceutical drug BENLYSTA. The $1,259.50 contract has a completion date of February 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 400 mg vials of the pharmaceutical product BENLYSTA. The delivery order, valued at $1,259.50, has a completion date of March 19, 2024 and was awarded on February 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, through December 31, 2025, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 400 mg vials of the pharmaceutical BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical product BENLYSTA. The award has a potential value of $1,259.50 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 400 mg vials of the drug BENLYSTA. The contract has a potential value of $13,854.50 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical product BENLYSTA. The $1,259.50 order has a completion date of March 12, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical drug BENLYSTA. The contract has a potential value of $1,259.50 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,557.00 contract is for the supply of 400 mg vials of the specialty pharmaceutical BENLYSTA to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,557 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the supply of 400 mg vials of the pharmaceutical product BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product BENLYSTA 200 mg/mL syringe. The $8,372.94 delivery order has a completion date of March 26, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9URDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation, to supply 400 mg vials of the specialty biologic medication BENLYSTA. The $7,557.00 delivery order has a completion date of March 13, 2024 and was awarded on February 21, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs. The contract does not have a set-aside designation.
Generated 5/22/24, 10:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 2/21/24 |